- Home
- FLNT vs ICCC Comparison
FLNT vs ICCC Comparison
Compare FLNT & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ICCC
- Stock Information
- Founded
- FLNT 2001
- ICCC 1982
- Country
- FLNT United States
- ICCC United States
- Employees
- FLNT N/A
- ICCC N/A
- Industry
- FLNT Advertising
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- ICCC Health Care
- Exchange
- FLNT Nasdaq
- ICCC Nasdaq
- Market Cap
- FLNT 54.9M
- ICCC 48.3M
- IPO Year
- FLNT N/A
- ICCC 1987
- Fundamental
- Price
- FLNT $2.32
- ICCC $5.07
- Analyst Decision
- FLNT Hold
- ICCC
- Analyst Count
- FLNT 1
- ICCC 0
- Target Price
- FLNT $3.50
- ICCC N/A
- AVG Volume (30 Days)
- FLNT 14.7K
- ICCC 27.6K
- Earning Date
- FLNT 05-16-2025
- ICCC 05-14-2025
- Dividend Yield
- FLNT N/A
- ICCC N/A
- EPS Growth
- FLNT N/A
- ICCC N/A
- EPS
- FLNT N/A
- ICCC N/A
- Revenue
- FLNT $254,623,000.00
- ICCC $26,493,169.00
- Revenue This Year
- FLNT $9.20
- ICCC N/A
- Revenue Next Year
- FLNT $8.67
- ICCC N/A
- P/E Ratio
- FLNT N/A
- ICCC N/A
- Revenue Growth
- FLNT N/A
- ICCC 51.63
- 52 Week Low
- FLNT $2.01
- ICCC $3.34
- 52 Week High
- FLNT $4.30
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- FLNT 48.01
- ICCC 42.10
- Support Level
- FLNT $2.15
- ICCC $5.01
- Resistance Level
- FLNT $2.65
- ICCC $5.72
- Average True Range (ATR)
- FLNT 0.25
- ICCC 0.18
- MACD
- FLNT -0.01
- ICCC -0.05
- Stochastic Oscillator
- FLNT 30.91
- ICCC 14.96
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.